The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients (CROSBI ID 573172)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Pavićević, Radomir ; Bialk, Peter ; Bubanović, Gordana ; Krajna, Ana ; Samaržija, Miroslav ; Pavićević, Lukrecija
engleski
The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients
The clinical application of cytokeratin marker CYFRA 21-1 was standardized on 2000 patients. In all patients the start value of CYFRA 21-1 was determined before therapy (Roche Diagnostics). Tumor marker CYFRA 21-1 was assessed longitudinally 1 to 36 months after the therapy, or before the next therapy. One to three months after the surgical treatment in 87% of the patients the marker values decreased to the healthy population level, depending on the therapy and TNM stage (p<0.0001). The …
CYFRA 21-1; lung cancer
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
485-485.
2001.
objavljeno
Podaci o matičnoj publikaciji
ATS 97th International Conference Abstract Book
New York (NY): American Thoracic Society (ATS)
Podaci o skupu
ATS 97th International Conference
predavanje
18.05.2001-23.05.2001
San Francisco (CA), Sjedinjene Američke Države
